Jardiance fails to deliver in EMPERIAL trials for heart failure
The trial failure places doubt on the success of Jardiance in further trials for HF-REF and HF-PEF and may impact the uptake of the drug.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more